# SSRI-stroke


*SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND RISK OF NON-CARDIOEMBOLIC ATHEROTHROMBOTIC ISCHEMIC STROKE: A NESTED CASE-CONTROL STUDY 

*Rasha Alqdwah-Fattouh, MPH1; Sara Rodríguez-Martín, PhD2,3; Diana Barreira-Hernández, PharmD2,3; Laura Izquierdo, MD4; Miguel Gil, PhD5; Diana González-Bermejo, PhD5; Encarnación Fernández-Antón, PharmD2,3; Antonio Rodríguez-Miguel, PhD2,3; Alberto García-Lledó, PhD6,7; Prof. Francisco Bolumar, PhD1,8,9; Prof. Francisco J de Abajo, PhD2,3

*1Unit of Epidemiology and Public Health. School of Medicine, University of Alcalá, Madrid, Spain.
*2Clinical Pharmacology Unit, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.  
*3Department of Biomedical Sciences (Pharmacology Sector), School of Medicine, University of Alcalá (IRYCIS), Alcalá de Henares, Madrid, Spain. 
*4Stroke Unit, Department of Neurology, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
*5Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices, Madrid, Spain. 
*6Cardiology Department, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
*7Department of Medicine, School of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain.
*8Department of Epidemiology and Biostatistics. Graduate School of Public Health. City University of New York. New York, NY 10027
*9CIBERESP, Spain
